New Arthroscopy Tubing Guidance Aims To Reduce Cross-Contamination
Executive Summary
Developers of arthroscopy tubing should take additional steps to reduce the risk of patient cross-contamination, the US FDA recommends in a new draft guidance document.
You may also be interested in...
FDA Finalizes Guidance On Multi-Patient Arthroscopy Tubing
The document from the US agency details features and testing protocols expected to diminish the risk of “backflow,” in which contaminated fluid is transferred from one patient to another.
‘Right Product, Right Time:’ FDA Clears Boston Scientific's Single-Use Duodenoscope
Amid concerns of infections from duodenoscopes that are not sufficiently re-sterilized, the US FDA has cleared Boston Scientific’s Exalt-D as a the first single-use duodenoscope. Investors expect the device will likely take a significant chunk of the market, especially considering the next competitor is at least a year away.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.